Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine

Part of paid clinical trials in East Providence, Rhode Island.

Sponsor
Association of Migraine Disorders
Study ID
NCT07571889
Status
Recruiting

Conditions

  • Pain From onabotulinumtoxinA Injections

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • onabotulinumtoxinA prophylaxis with Lidocaine — PROCEDURE
    The onabotulinumtoxinA prophylaxis procedure is the modified PREEMPT protocol consisting of 56 injections; 200 Units. The solution from the vial (lidocaine) will be dripped onto 2 small pieces of cotton. One piece of cotton will be placed in the anterior portion of the nasal cavity on each side of the nose. The cotton will be removed after 5 minutes. The clinician will then perform the various series of injections while assessing pain of the injection site following each series of injections.
  • OnabotulinumtoxinA prophylaxis with Saline — PROCEDURE
    The onabotulinumtoxinA prophylaxis procedure is the modified PREEMPT protocol consisting of 56 injections; 200 Units. The solution from the vial (Saline) will be dripped onto 2 small pieces of cotton. One piece of cotton will be placed in the anterior portion of the nasal cavity on each side of the nose. The cotton will be removed after 5 minutes. The clinician will then perform the various series of injections while assessing pain of the injection site following each series of injections.

Study Details

People find the injections used in onabotulinumtoxinA (Botox®) uncomfortable. This study will test whether putting a small piece of cotton soaked with 4% lidocaine (a numbing medicine) inside the front of each nostril for 5 minutes before the injections reduces injection pain compared with cotton soaked in saline (salt water).

Key Dates

Start date
Mar 3, 2026
Status verified
May 2026
Primary completion
Jan 31, 2027
Completion
Jan 31, 2027

Study Design

Enrollment
18 participants (estimated)
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION

Arms

  • Experimental: Lidocaine
    Intranasal 4% lidocaine: vial with 1ml solution with added flavor
  • Placebo Comparator: Saline
    Vial with 1ml liquid containing 0.9% sodium chloride solution with identical flavor

Primary Outcome Measure

Overall patient-reported injection pain [ Time Frame: Immediately before and immediately following the procedure at Study Visit 1 and again 12 weeks later at Study Visit 2. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University OtolaryngologyEast ProvidenceRhode Island02905
Frederick Godley III, MD
401-274-2300

Find similar trials in East Providence, RI